Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
315 Leser
Artikel bewerten:
(1)

Sectra signs subscription-based enterprise imaging contract with Dayton Children's Hospital in US

LINKÖPING, Sweden and SHELTON, CT, Dec. 3, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its enterprise imaging solution to Dayton Children's Hospital. They will utilize the platform's radiology and cardiology modules as well as the multi-media archive VNA, to store all medical images throughout the health system. This unified imaging platform, tightly integrated with Epic Radiant, will provide all caregivers a full patient overview regardless of their reading location.

Dayton Children's is a teaching hospital providing primary and subspecialty ambulatory and acute inpatient care for Dayton, Ohio, and its 20-county service area. In addition to its 181-bed main campus hospital, it has 12 outpatient locations providing emergent, urgent, and routine care.

The contract, signed in October, provides enterprise imaging as a subscription service (Sectra One). This will allow Dayton Children's the ability to easily expand into other specialties and gain access to new functionality, as it becomes available. Acquiring enterprise imaging as a subscription provides a more efficient way of scaling the system as volumes grow.

"I am happy to welcome Dayton Children's as a Sectra One customer. Their goal of eliminating silos and creating a unified imaging platform aligns well with Sectra's enterprise functionality. Patients and providers will have access to a complete electronic health record," says Anthony Grise, Vice President of Sales at Sectra, Inc.

Sectra's enterprise imaging solution provides a complete and robust system armed with efficient and accurate clinical tools, proven to boost productivity and improve collaboration. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. The offering includes a module for full-scale digital pathology, which received FDA approval in the US in March 2020. Read more about Sectra's enterprise imaging solution and why Sectra PACS is ranked "Best in KLAS" for seven consecutive years at medical.sectra.com.

Epic and Radiant are registered trademarks of Epic Systems Corporation.

About Sectra

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit sectra.com.

For further information, please contact:

Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705 23 52 27

Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/sectra-signs-subscription-based-enterprise-imaging-contract-with-dayton-children-s-hospital-in-us,c3248006

The following files are available for download:

https://news.cision.com/sectra/i/sectra-s-enterprise-imaging-solution,c2856784

Sectra's enterprise imaging solution

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.